Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GROningen INternational Study on Sentinel Nodes in Vulvar Cancer (GROINSS-V) II: An Observational Study

NCT01500512 is registered in ClinicalTrials.gov with Gynecologic Oncology Group as lead sponsor.

NCT NCT01500512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01500512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GROningen INternational Study on Sentinel Nodes in Vulvar Cancer (GROINSS-V) II: An Observational Study
Lead sponsor
Gynecologic Oncology Group
Phase
Observational
Overall status
Unknown status
Start date
January 3, 2012
Completion date
Not reported
Enrollment
148 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

stage i vulvar cancer, stage ii vulvar cancer, stage iii vulvar cancer, vulvar squamous cell carcinoma